Clinical Impact of New COVID-19 Data From IDWeek 2020 Virtual

Source: 2020 IDWeek*
October 21-25, 2020; Virtual Conference
In this downloadable slideset, CCO’s expert faculty summarize key COVID-19 studies from this important conference, including new data on transmission in different settings, symptom progression and clinical outcomes, detection of non-SARS-CoV-2 viruses during the COVID-19 pandemic, and treatment and prevention strategies.
Rajesh T. Gandhi, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 731 KB
Released: November 5, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by:
Gilead Sciences, Inc.

Related Content

Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)

Vikramjit Mukherjee, MD Released: February 19, 2021

Download free slides reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis, symptoms, management, and treatment

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: February 9, 2021

Dr. Jens D. Lundgren reviews diagnostic tests for SARS-CoV-2 infection, contrasting antigen tests with nucleic acid assays, and describing how to use and interpret antigen tests from Clinical Care Options (CCO)

Jens D. Lundgren, MD, DMSc Released: January 29, 2021

Dr. Arthur Kim reviews EUAs for baricitinib, bamlanivimab, and casirivimab/imdevimab, and NIH Guideline on ivermectin from Clinical Care Options (CCO)

Arthur Kim, MD Released: January 25, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue